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Vaccine manufacturing costs and production limitations represent two 
fundamental challenges facing researchers, public health officials and vaccine 
manufacturers committed to global health solutions. To address these issues, 
we have investigated whether the cell lines employed by vaccine 
manufacturers can be engineered to enhance vaccine virus production.  As a 
first step in a proof-of-principle study, a genome-wide RNA Interference 
(RNAi) screen was conducted to identify host gene modulation events that 
increased Sabin 2 poliovirus (PV) replication. Primary screen hits were 
validated in a Vero vaccine manufacturing cell line using both attenuated and 
wild type poliovirus strains. This approach identified multiple single and dual 
gene knockdown events that increased PV titers >20-fold and >50-fold, 
respectively. Top candidate genes did not affect virus antigenicity, cell 
viability, or cell doubling times. Moreover, CRISPR/Cas9-mediated knockout 
(KO) of the top three targets created stable cell substrates with improved viral vaccine strain production 
 (Figure 1). Interestingly, silencing of several genes that enhanced PV replication also boosted replication of 
enterovirus 71, a clinically relevant virus for which vaccines are being targeted. The discovery that host gene 
modulation can markedly increase virus vaccine production identifies a strategy to address current public health 






Figure 1 – Plaque Assays. 
Knockout of individual host 
genes dramatically enhances 
poliovirus production 
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